Single award · contract

Advancement of Hemamax Towards Bla Submission for the Mitigation of Hsars Under the FDA Animal Rule

Award ID: HHSO100201100037C

A single federal award, with both ends of the trail linked.

$51M
Total award value

Award HHSO100201100037C is a contract from the Department of Health and Human Services, $51M obligated, FY2011 to FY2018, for Advancement of Hemamax Towards Bla Submission for the Mitigation of Hsars Under the FDA Animal Rule. The work is performed in California. It is classified as PSC 6505 (Drugs and Biologicals) and NAICS 541711 (Research and Development in Biotechnology). Source

Agency ›
Department of Health and Human Services
Source
awarded→$51M
State ›
California
Source

Award details

Award typeContract
PIIDHHSO100201100037C
Action date2011
Period84 mo
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceCalifornia →
CategoryPSC 6505NAICS 541711
Competed?Not recordedSource
Total (exact)$50,997,157

More from Department of Health and Human Services

Medicaid Entitlement for 7 - Fy 2026 - T19
awarded 2025$110.4B
Medicaid Entitlement for 7 - Fy 2026 - T19
awarded 2024$100.1B
Medicaid Entitlement for 7 - Fy 2025 - T19
awarded 2023$92B
Medicaid Entitlement for 7 - Fy 2024 - T19
awarded 2022$80.5B
Medicaid Entitlement for 7 - Fy 2023 - T19
awarded 2021$80.5B
All awards from this agency →
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.